We observed that loss of B2m significantly rescued the progression of tumors derived from Pikfyve-null cancer cells (Fig. 3I and SI Appendix, Fig. S4D), supporting that the tumor control mediated by Pikfyve-loss was also mediated by tumor-specific MHC-I expression. This evidence concerns the gene B2M and cancer.